BU-NOT-SET

CONTACT US
Is outsourcing the most viable pathway for innovators?
  • Manufacturing
Meeting
Insight
Developing a generic prolonged-release isosorbide-5-mononitrate tablet
  • Drug product
Two lab workers
Case study
Recipharm Wins two 2020 CMO Leadership Awards
  • Industry trends
Eyes
Insight
Recipharm’s global teams support and engage with their local communities in the fight against COVID-19
  • Corporate
Eyes
Insight
Recipharm launches new virtual inspection and audit tool for customers, in light of COVID-19 outbreak
  • Manufacturing
Eyes
Insight
Recipharm 25 years
  • Corporate
24 years
Brochure
API product list
  • Drug substance
white pills
Fact sheet
Inhibition of 19S proteasome deubiquitinating activity in Schistosoma mansoni affects viability, oviposition, and structural changes
  • Drug substance
Eyes
Insight
The demand for antibiotics and its impact on the pharmaceutical industry since the outbreak of COVID-19
  • Industry trends
Eyes
Insight
Insight
  • Drug product
  • Manufacturing
How pre-filled syringes are changing drug delivery of biologics
Webinar
  • Drug product
Choosing the right sterile container for your drug product
Video
  • Manufacturing
ReciBioPharm is advancing the future of xRNA manufacturing
Webinar
  • Biologics
  • Manufacturing
Faster, smaller, smarter: Intelligent manufacturing of mRNA through the power of process analytical technologies
Insight
  • Biologics
ReciBioPharm: The Economic Case for Continuous Manufacturing
Insight
  • Drug product
  • Manufacturing
The innovation bottleneck: Why drug development is so tough, and how connectivity and predictive analysis can overcome obstacles
Insight
  • Industry trends
What are the key trends shaping drug development in 2025?
Insight
  • Biologics
ReciBioPharm Is Advancing xRNA Production
eBook
  • Drug product
  • Manufacturing
Navigating the complexities of pre-filled syringes for biologics